Aromatase inhibitors are the standard adjuvant hormone therapy for postmenopausal women with hormone-sensitive breast cancer.

Objectives To explore the mental health literacy of school communities and stigma against students with mental disorders in Ethiopia’s specific context. Design Qualitative study using in-depth and key ...

Draft legislation for treasurer Jim Chalmers’ new instant tax deduction policy lands just over a year after Labor proposed the change in the run-up to the 2025 election Get our breaking news email, ...

Inductive Bible study offers a simple yet powerful way to move from surface-level reading to deep understanding of Scripture. By focusing on observation, interpretation, and application, it helps ...

I’ve been wearing Salomons on and off since I was a teen, but as my most recent pair of basic black XT Wings nears their end (after an impressive six-year run), I’m ready to move on. After considering ...

Alperen Şengün struggled to make an offensive impact for the Houston Rockets in Game 1 against the Los Angeles Lakers. Sean M. Haffey / Getty Images LOS ANGELES — Once it became official that Kevin ...

Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial. Neoadjuvant ...

The next three weeks could be crucial for Sheffield Wednesday, as they look to complete a takeover which will secure the club's future. David Storch and his Arise Capital Partners consortium have ...

First study combining botensilimab (BOT) and balstilimab (BAL) with agenT-797 in gastroesophageal cancer shows disease control rate (DCR) of 77% in patients and long-term survival beyond 20 months in ...

At SNHU, we want to make sure you have the information you need to make decisions about your education and your future—no matter where you choose to go to school. That's why our informational articles ...

Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract ...